Supplemental Table 2 from Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer
Julien Dilly(Massachusetts Institute of Technology), Brian M. Wolpin(Brigham and Women's Hospital), Brendan D. Parent(Broad Institute), Anastasia M. Lopez(The University of Texas MD Anderson Cancer Center), Jill Hallin(Mirati Therapeutics (United States)), Kevin S. Kapner(Broad Institute), Shatavisha Dasgupta(Dana-Farber Cancer Institute), Christopher A. Bristow(The University of Texas MD Anderson Cancer Center), Francesca Paradiso(The University of Texas MD Anderson Cancer Center), Hanrong Feng(Dana-Farber Cancer Institute), Kenna Anderes(Mirati Therapeutics (United States)), Connor J. Hennessey(Broad Institute), Jacob Geisberg(Harvard University), Scott W. Lowe(Howard Hughes Medical Institute), David S. Hong(The University of Texas MD Anderson Cancer Center), Aislyn Schalck(The University of Texas MD Anderson Cancer Center), Micaela Morgado(Dana-Farber Cancer Institute), Megan T. Hoffman(Massachusetts Institute of Technology), Seema Chugh(Broad Institute), Eliezer M. Van Allen(Broad Institute), Michael P. Kim(The University of Texas MD Anderson Cancer Center), Kimal Rajapakshe(Baylor College of Medicine), Peter Olson(RIKEN BioResource Research Center), Ziyue Li(Broad Institute), Giselle A. Uribe(Broad Institute), Anirban Maitra(Johns Hopkins University), Laleh Abbassi(Broad Institute), Jennifer A. Roth(Broad Institute), Ben Z. Stanger(Cancer Research Institute), Paola A. Guerrero(The University of Texas MD Anderson Cancer Center), Hengyu Lyu(The University of Texas MD Anderson Cancer Center), Timothy P. Heffernan(The University of Texas MD Anderson Cancer Center), Abraham Anderson(Amgen (United States)), Felix P. Hambitzer(Dana-Farber Cancer Institute), Alexander C. Jordan(Broad Institute), Ningping Feng(The University of Texas MD Anderson Cancer Center), Kyle E. Evans(Broad Institute), James G. Christensen, Joseph D. Mancias(Brigham and Women's Hospital), Simona Cristea(Harvard University), Alex K. Shalek(Broad Institute), Shubham Pant(The University of Texas MD Anderson Cancer Center), Yuliya V. Katlinskaya(Amgen (United States)), Kavita S. Garg(Maxygen (United States)), Vahid Bahrambeigi, Qiang Li(Harvard University), A.K.M. Shamsuddin and Guang-Yu Yang, Junning Wang(Dana-Farber Cancer Institute), Emily Chan(University of Melbourne), Timour Baslan(University of Pennsylvania)
Cited by 0
Related Papers
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.2k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k